Amersham Biosciences Reorganizes, Cuts 400 Jobs | GenomeWeb

NEW YORK, Feb. 27 -- Amersham PLC, the parent company of Amersham Biosciences of Piscataway, NJ, and the UK-based diagnostic imaging business Amersham Health, announced Wednesday that it would undertake to bring the discovery systems portion of the Biosciences business -- the company's only unprofitable division -- into profitability by 2004.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.